Galderma Acquires CollaGenex For $420 Million
This article was originally published in The Pink Sheet Daily
Executive Summary
Swiss firm fattens dermatological portfolio with acquisition.
You may also be interested in...
CollaGenex, QuatRx Agree To Develop Topical Psoriasis Treatment
CollaGenex tells “The Pink Sheet” DAILY it expects to launch becocalcidiol for treatment of psoriasis between late 2010 and early 2012.
CollaGenex Will Launch Oracea In July With Specialty Sales Force
Oracea cleared FDA as the first orally administered, systemically delivered drug to treat rosacea.
Pharma's Reform Bounce: How Big a Bounce Will $80 Bil. Buy?
Drug manufacturers made a pledge to contribute $80 bil. in a mix of savings and revenue-raising initiatives to help fund health reform. In return, they could see a wide range of new business depending on how you look at the numbers.